ADVM
Price
$2.32
Change
-$0.17 (-6.83%)
Updated
Jun 27 closing price
Capitalization
48.47M
RANI
Price
$0.55
Change
+$0.03 (+5.77%)
Updated
Jun 27 closing price
Capitalization
18.53M
38 days until earnings call
Interact to see
Advertisement

ADVM vs RANI

Header iconADVM vs RANI Comparison
Open Charts ADVM vs RANIBanner chart's image
Adverum Biotechnologies
Price$2.32
Change-$0.17 (-6.83%)
Volume$2.8M
Capitalization48.47M
Rani Therapeutics Holdings
Price$0.55
Change+$0.03 (+5.77%)
Volume$1.23M
Capitalization18.53M
ADVM vs RANI Comparison Chart in %
Loading...
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADVM vs. RANI commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADVM is a Buy and RANI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (ADVM: $2.32 vs. RANI: $0.55)
Brand notoriety: ADVM and RANI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADVM: 630% vs. RANI: 227%
Market capitalization -- ADVM: $48.47M vs. RANI: $18.53M
ADVM [@Biotechnology] is valued at $48.47M. RANI’s [@Biotechnology] market capitalization is $18.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADVM’s FA Score shows that 0 FA rating(s) are green whileRANI’s FA Score has 0 green FA rating(s).

  • ADVM’s FA Score: 0 green, 5 red.
  • RANI’s FA Score: 0 green, 5 red.
According to our system of comparison, ADVM is a better buy in the long-term than RANI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADVM’s TA Score shows that 3 TA indicator(s) are bullish while RANI’s TA Score has 3 bullish TA indicator(s).

  • ADVM’s TA Score: 3 bullish, 4 bearish.
  • RANI’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, RANI is a better buy in the short-term than ADVM.

Price Growth

ADVM (@Biotechnology) experienced а +3.11% price change this week, while RANI (@Biotechnology) price change was +10.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

RANI is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADVM($48.5M) has a higher market cap than RANI($18.5M). ADVM YTD gains are higher at: -50.321 vs. RANI (-59.708). RANI has higher annual earnings (EBITDA): -48.83M vs. ADVM (-154.84M). ADVM has more cash in the bank: 83.1M vs. RANI (15.9M). RANI has less debt than ADVM: RANI (25.7M) vs ADVM (93.2M). RANI has higher revenues than ADVM: RANI (1.2M) vs ADVM (1M).
ADVMRANIADVM / RANI
Capitalization48.5M18.5M262%
EBITDA-154.84M-48.83M317%
Gain YTD-50.321-59.70884%
P/E RatioN/AN/A-
Revenue1M1.2M83%
Total Cash83.1M15.9M523%
Total Debt93.2M25.7M363%
FUNDAMENTALS RATINGS
ADVM: Fundamental Ratings
ADVM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADVMRANI
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
82%
Momentum
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
83%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
83%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INUV4.410.38
+9.43%
Inuvo
SAR24.680.09
+0.37%
SARATOGA INVESTMENT Corp
JBGS17.480.03
+0.17%
JBG SMITH Properties
JSAIY15.97-0.18
-1.11%
J Sainsbury plc
NBIS51.84-0.76
-1.44%
Nebius Group N.V.

ADVM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADVM has been loosely correlated with TENX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ADVM jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADVM
1D Price
Change %
ADVM100%
-6.83%
TENX - ADVM
48%
Loosely correlated
-1.34%
CCCC - ADVM
48%
Loosely correlated
-7.89%
IMNM - ADVM
47%
Loosely correlated
-0.23%
OCUL - ADVM
45%
Loosely correlated
-2.54%
XENE - ADVM
44%
Loosely correlated
+0.62%
More

RANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, RANI has been loosely correlated with XENE. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if RANI jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RANI
1D Price
Change %
RANI100%
+6.77%
XENE - RANI
35%
Loosely correlated
+0.62%
ADVM - RANI
32%
Poorly correlated
-6.83%
VYGR - RANI
30%
Poorly correlated
-0.34%
OCUL - RANI
29%
Poorly correlated
-2.54%
VNDA - RANI
29%
Poorly correlated
-0.83%
More